Arrayjet announces expansion plans as it broadens overseas reach
Midlothian-based Arrayjet has created seven new jobs across its core science, engineering and commercial units – taking its total team to 25.
The microarray tech firm says it has increased its staffing levels to help facilitate its international expansion and has recently started designing and developing a new bio-printing tech product which is scheduled to launch in 2018.
Its new recruits are Chief Engineer David Crabb; Application Scientist Maya Kowalewska; Senior Applications Scientist Catriona Ford; Commercial Manager, Europe & Middle East, Ranald Pringle; Commercial Manager, North America, Gavin Boothroyd; Commercial Manager, Asia Pacific Andrew Tomlins, and Administrative Assistant Stephanie Kennedy.
Arrayjet says its existing staff have been given responsibility for new territories. Saloni Sonawala has split her role as Business Development Executive to assume responsibility of developing new business opportunities across the Indian subcontinent, for example, while Russell Brown now has overall responsibility for Arrayjet’s Commercial Operations.
There are three additional engineering roles being created later in 2017.
Chief Executive Officer Iain McWilliam said: “A recent heavily oversubscribed round of funding via Archangel Investment Syndicate and a strong year on year 25% revenue growth is testament to our proven ability to develop and nurture new business.
“An appetite for new business and a belief in our business model underpinned 2016 as a year in which we continued a programme of successful expansion. Arrayjet is on a very sound footing as a profitable, expanding, Scottish-based and international player in the biomedical sector.”
The company expanded into new markets during 2016, as well as increasing its presence in existing key markets. Arrayjet now has a presence in 27 countries, across five continents and is supported by investment from business angel syndicate the Archangels.
Mike Rutterford of Archangels said: “Arrayjet remains one of the shining beacons within the Scottish life sciences industry and the new appointments, healthy international order book and, most importantly, the vision to establish and grow new territories underlines just how vital this business is to the life sciences landscape in Scotland.”